Screener
aTyr Pharma ATYR Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $16.16M-6.2% | $10.01M-3.4% | $10.74M-2.8% | $6.15M-46.3% | $17.22M+153% | ||
| $41.26M-34.6% | $56.51M-14.4% | $67.94M+11.3% | $84.05M+54.1% | $63.13M-11.9% | ||
| $58.36M-33.3% | $67.58M-18.8% | $80.24M-2.1% | $93.01M+21.9% | $87.49M-3.1% | ||
| $4.13M-8.8% | $4.24M-9.5% | $4.26M-12.1% | $4.43M-11.8% | $4.53M-12.7% | ||
| $69.83M-31.2% | $79.65M-18.1% | $93M-4.0% | $106.65M+16.4% | $101.53M-4.2% | ||
| $3.24M-16.5% | $2.76M+79.9% | $3.89M-10.0% | $4.06M+2.9% | $3.88M+209% | ||
| $518K-7.8% | $596K+8.4% | $630K+16.5% | $630K+19.3% | $562K+8.7% | ||
| $11.4M-26.6% | $11.7M+9.5% | $15.15M+1.2% | $15.68M+11.0% | $15.53M+31.2% | ||
| $98K+5.4% | $98K+10.1% | $98K+16.7% | $98K+28.9% | $93K+22.4% | ||
| -$627.26M-10.7% | -$616.96M-12.8% | -$606.16M-13.9% | -$592.2M-14.5% | -$566.46M-13.3% | ||
| $48.79M-34.8% | $57.93M-22.8% | $67.48M-3.6% | $80.24M+22.8% | $74.85M-8.3% | ||
| $69.83M-31.2% | $79.65M-18.1% | $93M-4.0% | $106.65M+16.4% | $101.53M-4.2% |
FAQ
- What are aTyr Pharma's total assets?
- aTyr Pharma (ATYR) holds $69.8M in total assets, down 31.2% year over year.
- How much debt does aTyr Pharma have?
- aTyr Pharma carries $11.8M in total debt against $48.8M of shareholders' equity, a debt-to-equity ratio of 0.24.
- How much cash does aTyr Pharma have?
- aTyr Pharma holds $16.2M in cash and equivalents.
- Can aTyr Pharma cover its short-term obligations?
- Its current ratio is 5.12 — current assets exceed current liabilities.
- Where does aTyr Pharma's balance sheet data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.